CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,540,294 | +93.7% | 51,792 | +17.3% | 0.00% | – |
| Q2 2023 | $795,313 | +59.8% | 44,135 | +42.4% | 0.00% | – |
| Q1 2023 | $497,603 | +6420.8% | 30,984 | +7330.2% | 0.00% | – |
| Q4 2022 | $7,631 | -59.8% | 417 | -57.3% | 0.00% | – |
| Q3 2022 | $19,000 | -29.6% | 976 | -35.8% | 0.00% | – |
| Q2 2022 | $27,000 | -80.0% | 1,521 | -75.3% | 0.00% | – |
| Q1 2022 | $135,000 | -78.5% | 6,156 | -72.2% | 0.00% | – |
| Q4 2021 | $628,000 | +694.9% | 22,115 | +325.7% | 0.00% | – |
| Q1 2021 | $79,000 | -75.8% | 5,195 | -77.6% | 0.00% | – |
| Q4 2020 | $327,000 | +5.1% | 23,193 | +16.9% | 0.00% | – |
| Q3 2020 | $311,000 | -12.4% | 19,839 | -2.1% | 0.00% | – |
| Q2 2020 | $355,000 | +258.6% | 20,256 | +199.7% | 0.00% | – |
| Q1 2020 | $99,000 | -57.3% | 6,759 | -27.1% | 0.00% | – |
| Q4 2019 | $232,000 | -33.9% | 9,275 | -60.2% | 0.00% | – |
| Q3 2019 | $351,000 | -30.5% | 23,309 | +15.4% | 0.00% | – |
| Q2 2019 | $505,000 | +117.7% | 20,199 | +98.0% | 0.00% | – |
| Q1 2019 | $232,000 | -23.4% | 10,200 | +0.9% | 0.00% | – |
| Q4 2018 | $303,000 | +212.4% | 10,105 | +198.5% | 0.00% | – |
| Q3 2018 | $97,000 | – | 3,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |